Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2025-12-24 @ 4:16 PM
NCT ID:
NCT00847366
Eligibility Criteria:
Inclusion Criteria:
* Patients must be currently receiving treatment with perifosine on a previously approved protocol.
* Patients must have had at least one evaluation following the initiation of treatment and have stable disease, partial response or complete response.
* Patient is willing to sign a new consent Regarding the protocol no exclusion criteria are described.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00847366
Study Brief:
Protocol Section:
NCT00847366